10-11, December 2024, Uchicago Center, Delhi
10-11, December 2024, Uchicago Center, Delhi
- A WORKSHOP
India, now the most populated country in the world, has the potential to become a global leader in drug development and clinical trials. Despite its vast population and diverse genetic pool, India’s participation in global clinical trials remains limited, making up only around 1.5% of trials worldwide. The need for well-trained personnel who can manage and lead clinical research is one of the significant challenges hindering India from being a competitive player in this space.
To address this, bcpbf-The Cancer Foundation & UCMS, in collaboration with the THE University of Chicago, Center in Delhi, is organizing a two-day workshop designed to equip participants with the essential skills to independently design and execute clinical trials. This workshop aims to bridge the knowledge gap, offering comprehensive training to early-career faculty, consultants, and advanced trainees on mastering clinical trial logistics, understanding the regulatory framework, and curating letters of intent for clinical trial funding. The aim is to develop a workforce capable of driving clinical research forward in India while training others at their institutions, ultimately positioning India as a more competitive player in global drug development.
Participants will be awarded certificates upon completion, and the program aims to expand annually to more cities across India, with a long-term vision of extending to other countries that face similar challenges in clinical trial development. By fostering a well-trained clinical research workforce, this initiative will help position India as a more competitive and attractive destination for global clinical trials, accelerating access to innovative treatments for its population.
Learn to independently develop clinical trials
Master clinical trial logistics and regulations
Curate a letter of intent for clinical trial funding
25
Early career faculty
Consultants
Advanced trainees
with experience in clinical research and an interest in clinical trials.
09.30-10.00
Registration/Tea
10:00-10.15
Introduction of workshop
10.15-10.45
Background research
10.45-11.15
Research questions
11.15-11.45
Break
11.45-12.15
Introduction of clinical trials
12.15-12.45
Aim and Objectives
12.45-13.15
CONSORT guidelines - overview
13.15-14.00
Lunch break
14.00-14.45
Study participants/Sample size
14.45-15.00
Intervention/Comparator
15.00-15.15
Break
15.15-15.45
Outcome measures (RECIST, Adverse events, safety)
17.00-17.30
Keynote – Journal as a clinical trialist
09.30-10.00
Tea
10:00-10.45
Keynote: Funding from foundations for clinical trials
10.45-11.30
Data analysis
11.30-12.00
Ethical considerations in clinical trials (India/International guidelines)
12.00-12.15
Break
12.15-13.00
Budget in clinical trials
13.00-13.45
Lunch break
13.45-16.30
Discussion of protocols (homework)
16.30-17.00
Patient advocate talk
17.00-17:30
Keynote - Regulatory perspective in oncology product development, from a US FDA standpoint”
Dr A.K Sharma
Dr Geetika Srivastava
Dr Khan Amir Maroof
Dr Navjeevan Singh
Dr Rajat Thawani
Dr Satendra Singh
Dr Suresh Ramalingam
Dr Tarunima Malik
Dr Upal Basu Roy
Dr Upreet Dhaliwal
Dr A.K Sharma
Dr Geetika Srivastava
Dr Khan Amir Maroof
Dr Navjeevan Singh
Dr Rajat Thawani
Dr Satendra Singh
Dr Suresh Ramalingam
Dr Tarunima Malik
Dr Upal Basu Roy
Dr Upreet Dhaliwal
DECEMBER | 10-11, 2024
9.30 AM - 5:30 PM
Media Room
Organizing Chairman
CliniTrial-2024
Organising Secretary
CliniTrial-2024
Conferences
ACCI 2022
SSCU 2019
ACCI 2017
The Gulmarg Declaration
Indo Nepal Cancer Symposium
Women & Cancer Srinagar
Women & Cancer Manipur
Oncohematology 2011
National workshop on liver cancer
More...
©2024 Breast Cancer Patients Benefit Foundation. | All Rights Reserved.